Webdisclosure.fr

Search

NICOX (EPA:COX) Bausch Health Announces Vyzulta® (latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved in South Korea

Directive transparence : information réglementée

09/02/2021 07:30